Rural Health
Resources by Topic: Cancer
Combined Prevalence of Chronic Conditions or Obesity for Adults in 2022
Examines the combined prevalence of obesity and chronic health conditions, including high blood pressure, cancer, and diabetes, among others, by demographic group, utilizing Medical Expenditure Panel Survey (MEPS) Household Component data. See Figure 6 for a comparison of prevalence between metropolitan statistical areas (MSAs) and non-MSAs.
Author(s): Zhengyi Fang, Rebecca Ahrnsbrak
Date: 08/2025
Sponsoring organization: Agency for Healthcare Research and Quality
view details
Examines the combined prevalence of obesity and chronic health conditions, including high blood pressure, cancer, and diabetes, among others, by demographic group, utilizing Medical Expenditure Panel Survey (MEPS) Household Component data. See Figure 6 for a comparison of prevalence between metropolitan statistical areas (MSAs) and non-MSAs.
Author(s): Zhengyi Fang, Rebecca Ahrnsbrak
Date: 08/2025
Sponsoring organization: Agency for Healthcare Research and Quality
view details
The Power of Prevention: "HPV Doesn't Wait – Why Should You?"
Discusses the Nebraska Cancer Coalition's "HPV Doesn't Wait - Why Should You?" public awareness campaign, which focuses on educating healthcare providers and community members throughout Nebraska on the value of human papillomavirus (HPV) vaccination. Details disparities in adolescent HPV vaccination rates in rural Nebraska and highlights the importance of rural outreach.
Author(s): Laura Schabloske, Tamara Robinson
Date: 08/2025
Sponsoring organization: St. Jude Children's Research Hospital
view details
Discusses the Nebraska Cancer Coalition's "HPV Doesn't Wait - Why Should You?" public awareness campaign, which focuses on educating healthcare providers and community members throughout Nebraska on the value of human papillomavirus (HPV) vaccination. Details disparities in adolescent HPV vaccination rates in rural Nebraska and highlights the importance of rural outreach.
Author(s): Laura Schabloske, Tamara Robinson
Date: 08/2025
Sponsoring organization: St. Jude Children's Research Hospital
view details
Community Navigation Intervention for Social Needs in Patients With Abnormal Mammography: A Randomized Controlled Trial Study Protocol
Presents a study exploring the efficacy of community navigators, such as 211, to help alleviate unmet social needs and change the likelihood of cancer patients with unmet social needs to complete their follow-up care. Discusses the importance of follow-up care in the treatment and prevention of cancer and the barriers individuals with unmet social needs face to receive it. Explores rurality as a potential barrier.
Author(s): Kirstin Beck, Mackenzie Mitchell, Andrea S. Wallace, et al.
Citation: BMC Public Health, 25, 2926
Date: 08/2025
view details
Presents a study exploring the efficacy of community navigators, such as 211, to help alleviate unmet social needs and change the likelihood of cancer patients with unmet social needs to complete their follow-up care. Discusses the importance of follow-up care in the treatment and prevention of cancer and the barriers individuals with unmet social needs face to receive it. Explores rurality as a potential barrier.
Author(s): Kirstin Beck, Mackenzie Mitchell, Andrea S. Wallace, et al.
Citation: BMC Public Health, 25, 2926
Date: 08/2025
view details
County-Level Cervical Cancer Screening Coverage and Differences in Incidence and Mortality
Research letter analyzing differences in cervical cancer incidence and mortality by rates of screening at the county level, utilizing SEER-22 database data. Identifies associations between county-level rurality, low income, and low repeat screening coverage. Highlights counties in Texas, Idaho, and New Mexico counties with low screening coverage and discusses targeted screening efforts in underserved areas.
Author(s): Trisha L. Amboree, Jane R. Montealegre, Haluk Damgacioglu, et al.
Citation: JAMA Network Open, 8(8), e2526709
Date: 08/2025
view details
Research letter analyzing differences in cervical cancer incidence and mortality by rates of screening at the county level, utilizing SEER-22 database data. Identifies associations between county-level rurality, low income, and low repeat screening coverage. Highlights counties in Texas, Idaho, and New Mexico counties with low screening coverage and discusses targeted screening efforts in underserved areas.
Author(s): Trisha L. Amboree, Jane R. Montealegre, Haluk Damgacioglu, et al.
Citation: JAMA Network Open, 8(8), e2526709
Date: 08/2025
view details
Rural and Urban Differences in Prostate Cancer Recurrence
Examines rates of prostate cancer recurrence among 778 rural and urban men, utilizing data from the North Carolina Prostate Cancer Comparative Effectiveness Survivor Study. Analyzes the association of rurality and other demographic and clinical factors with recurrence.
Author(s): Julia B. Balmaceda, Aaron J. Katz, Katelyn Kane, et al.
Citation: JAMA Network Open, 8(8), e2526912
Date: 08/2025
view details
Examines rates of prostate cancer recurrence among 778 rural and urban men, utilizing data from the North Carolina Prostate Cancer Comparative Effectiveness Survivor Study. Analyzes the association of rurality and other demographic and clinical factors with recurrence.
Author(s): Julia B. Balmaceda, Aaron J. Katz, Katelyn Kane, et al.
Citation: JAMA Network Open, 8(8), e2526912
Date: 08/2025
view details
Precision Public Health Alliances as a Model and Method for Community Engagement
Examines the Precision Public Health Alliance (PPHA) approach of utilizing analytics to map social, demographic, and clinical comorbidity variables onto colorectal cancer (CRC) screening data in rural northeastern Kentucky and southeastern Ohio. Provides data on the relationship among sociodemographic information, clinical outcomes, and CRC screening to assess community needs. Discusses the importance of understanding social determinants of health (SDOH) and community collaboration when addressing population health.
Author(s): Margaret L. McGladrey, Mary Elizabeth Lacy, Kristen McQuerry, et al.
Citation: Frontiers in Public Health, 13
Date: 08/2025
view details
Examines the Precision Public Health Alliance (PPHA) approach of utilizing analytics to map social, demographic, and clinical comorbidity variables onto colorectal cancer (CRC) screening data in rural northeastern Kentucky and southeastern Ohio. Provides data on the relationship among sociodemographic information, clinical outcomes, and CRC screening to assess community needs. Discusses the importance of understanding social determinants of health (SDOH) and community collaboration when addressing population health.
Author(s): Margaret L. McGladrey, Mary Elizabeth Lacy, Kristen McQuerry, et al.
Citation: Frontiers in Public Health, 13
Date: 08/2025
view details
Use of Cancer Screening Tests, United States, 2023
Examines use of screening tests for breast, cervical, and colorectal cancer (CRC). Utilizes 2023 National Health Interview Survey data to analyze percentage of adults who are up-to-date with screening recommendations according to age, sociodemographics, healthcare usage, and large central metropolitan, large fringe metropolitan, medium/small metropolitan, or nonmetropolitan location.
Author(s): Susan A. Sabatino, Trevor D. Thompson, Jennifer M. Croswell, et al.
Citation: Preventing Chronic Disease, 22
Date: 08/2025
view details
Examines use of screening tests for breast, cervical, and colorectal cancer (CRC). Utilizes 2023 National Health Interview Survey data to analyze percentage of adults who are up-to-date with screening recommendations according to age, sociodemographics, healthcare usage, and large central metropolitan, large fringe metropolitan, medium/small metropolitan, or nonmetropolitan location.
Author(s): Susan A. Sabatino, Trevor D. Thompson, Jennifer M. Croswell, et al.
Citation: Preventing Chronic Disease, 22
Date: 08/2025
view details
Baseline Estimates of Colorectal Cancer Screening Among Adults Aged 45 to 75 Years, Behavioral Risk Factor Surveillance System, 2022
Examines colorectal cancer (CRC) screening rates for adults aged 45 to 75. Utilizes 2022 Behavioral Risk Factor Surveillance System survey data to analyze CRC screening status according to respondent demographics, income, access to healthcare and health plans, and metro versus nonmetro location.
Author(s): Sallyann Coleman King, Jessica King, Cheryll C. Thomas, Lisa C. Richardson
Citation: Preventing Chronic Disease, 22
Date: 08/2025
view details
Examines colorectal cancer (CRC) screening rates for adults aged 45 to 75. Utilizes 2022 Behavioral Risk Factor Surveillance System survey data to analyze CRC screening status according to respondent demographics, income, access to healthcare and health plans, and metro versus nonmetro location.
Author(s): Sallyann Coleman King, Jessica King, Cheryll C. Thomas, Lisa C. Richardson
Citation: Preventing Chronic Disease, 22
Date: 08/2025
view details
Trends in Pulmonary Embolism Mortality in Cancer Patients in the United States from 1999-2022 – A CDC Wonder Database Study
Examines mortality rates from pulmonary embolism (PE) in cancer patients. Utilizes 1999-2022 Centers for Disease Control's Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) data to analyze 214,756 deaths, with breakdowns according to demographic variables, U.S. region, state, and rural versus urban location.
Author(s): Elizabeth Dort, Hannah Rud, Taylor Billion, Abubakar Tauseef
Citation: Respiratory Research, 26, 248
Date: 07/2025
view details
Examines mortality rates from pulmonary embolism (PE) in cancer patients. Utilizes 1999-2022 Centers for Disease Control's Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) data to analyze 214,756 deaths, with breakdowns according to demographic variables, U.S. region, state, and rural versus urban location.
Author(s): Elizabeth Dort, Hannah Rud, Taylor Billion, Abubakar Tauseef
Citation: Respiratory Research, 26, 248
Date: 07/2025
view details
Cancer in Rural America: Improving Access to Clinical Trials and Quality of Oncologic Care
Discusses the importance of rural populations accessing oncologic clinical trials to decrease cancer morbidity and mortality rates in rural areas. Provides rural versus urban patient data on distance from trial sites as well as prevalence of chronic disease. Suggests strategies and policies to improve access to clinical trials.
Author(s): Joseph M. Unger, Barbara L. McAneny, Raymond U. Osarogiagbon
Citation: CA: A Cancer Journal for Clinicians, 75(4), 341-361
Date: 07/2025
view details
Discusses the importance of rural populations accessing oncologic clinical trials to decrease cancer morbidity and mortality rates in rural areas. Provides rural versus urban patient data on distance from trial sites as well as prevalence of chronic disease. Suggests strategies and policies to improve access to clinical trials.
Author(s): Joseph M. Unger, Barbara L. McAneny, Raymond U. Osarogiagbon
Citation: CA: A Cancer Journal for Clinicians, 75(4), 341-361
Date: 07/2025
view details